Mutational analysis of <i>PPARG</i> as a candidate tumour suppressor gene in enteropancreatic endocrine tumours
Jessica Costa‐Guda(University of Connecticut), Andrew Arnold(University of Connecticut), Evan D. Rosen(Broad Institute), Daniel C. Chung(Massachusetts General Hospital), Robert T. Jensen(National Institutes of Health)
Cited by 5
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Transcriptional regulation of adipogenesis
|Genes & Development|2000|1.9k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k